Skip to main content
OpenTrials

Clinical trial condition

EGFR Gene Mutation

Explore clinical trials studying EGFR Gene Mutation. Study availability and eligibility vary by location and protocol.

41 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

EGFR Gene Mutation trial results

Completed

A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies

NCT04042558

Conditions
ALK Gene Rearrangement Positive, Bronchial Neoplasms, Carcinoma, Bronchogenic, +12 more
Locations
  • CHU Angers, France
  • Centre Hospitalier Annecy, France
  • CHU-Hôpital MORVAN Brest, France
  • CHU Lyon Louis Pradel Bron, France
View all 31 locations
View Trial Details
Completed

A Pilot Study of Dacomitinib With or Without Osimertinib for Patients With Metastatic EGFR Mutant Lung Cancers With Disease Progression on Osimertinib.

NCT03755102

Conditions
EGFR Gene Mutation, Lung Cancer, Lung Cancer Metastatic, +7 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Completed

Clinical Trial of YH25448 in Patients with EGFR Mutation Positive Advanced NSCLC

NCT03046992

Conditions
Brain Diseases, Brain Neoplasms, Bronchial Neoplasms, +14 more
Locations
  • The Catholic University of Korea, Bucheon St. Mary's Hospital Bucheon-si, Gyeonggi-do, South Korea
  • National Cancer Center Goyang-si, Gyeonggi-do, South Korea
  • CHA Bundang Medical Center, CHA University Seongnam-si, Gyeonggi-do, South Korea
  • Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
View all 16 locations
View Trial Details

Related conditions